Rhodioloside attenuated atherosclerosis progression by inhibiting VCAM-1 gene transcription mediated by p65 activation and CSN5 deubiquitination in endothelial cells
Author:
Ji Jing1, Tang Wenlian1, Liu Xingquan2, Luo Lin3, Xin Xin3, Ju Nana3, Xiong Huarong3, Wu Ping3, Zhang Xian3, Zhang Daiwei3, Yu Lan3, Li Gen3, Zhao Feipeng3, Wang Jianing4, Liu Chao2, Zhang Xu3
Affiliation:
1. Jiangsu Ocean University 2. Nanjing Medical University 3. Affiliated Hospital of Integrated Traditional Chinese and Western Medicine of Chengdu Medical College 4. The Affiliated Jiangning Hospital with Nanjing Medical University
Abstract
Abstract
Monocyte-endothelial cell adhesion played a pivotal role in the initial stages of Atherosclerosis (AS) progression, exacerbating lipid disturbance and worsening the condition. Rhodioloside (Rho), a renowned compound in traditional Chinese medicine, possesses diverse pharmacological attributes, including anti-inflammatory, antioxidant, anticancer, anti-metabolic dysregulation, and neuroprotective properties. However, the exact mechanism by which Rho exerts its anti-AS effect is still not fully understood. This study aimed to investigate the potential therapeutic benefits of Rho in combating AS. ApoE−/− mice were fed with a High Fat Diet (HFD) and administered Rho treatment. The investigation evaluated the expression levels of GATA2, CSN5, and VCAM-1 proteins in the endothelium of the aorta. The findings revealed that Rho treatment led to a reduction in the protein expression of GATA2, CSN5, and VCAM-1 in the aortic endothelium, accompanied by decreased phosphorylation of p65. Furthermore, Rho inhibited the ubiquitination of GATA2 and weakened the interaction between PP2Ac and I2PP2A. Additionally, Rho directly suppressed the transcriptional activity of the NF-κB subunit p65 by targeting the I2PP2A-PP2Ac axis.
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt,M. S., … American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. (2022). Heart disease and stroke statistics—2022 update: a report from the American Heart Association. Circulation, 145(8), e153-e639. 2. Hu, S. S., Gao, R. L., Liu, L. S., Zhu, M. L., Wang, W., Wang, Y. J., … Chen, W. (2019).Summary of China cardiovascular disease report 2018. Chinese Circulation Journal, 34(03), 209–220 3. Endothelial glycocalyx, apoptosis and inflammation in an atherosclerotic mouse model;Cancel LM;Atherosclerosis,2016 4. Anti-inflammatory therapeutics for the treatment of atherosclerosis;Charo IF;Nat Rev Drug Discovery,2011 5. Effects of Huoxuoxu Traditional Chinese medicine on blood lipid and atherosclerotic plaque inflammation in ApoE gene-deficient mice;Wen Chuan X;Chin J Integr Traditional Western Med,2005
|
|